The latest memo inOncology SPECIAL ISSUE summarizes a selection of abstracts of clinical interest ranging from early-stage disease to the metastatic setting. This report brings the role of adjuvant chemotherapy as well as targeted options and sequencing issues with KRAS, HER2 and ALK mutations into focus. Moreover, novel treatment approaches in the EGFR-mutated NSCLC and small-cell lung cancer, relapsed malignant mesothelioma or pretreated NSCLC are among other topics reviewed.

As an additional feature, you will find expert video interviews with Alex Spira, Sandip Patel, Luis M. Montuenga & Ming Tsao on different conference highlights on our website.

Access an article directly (English):

▲  Preface – WCLC 2020

▲ Improved median PFS for patients with late-stage non-squamous NSCLC treated with first-line sintilimab plus conventional chemotherapy regimen

▲Ensartinib outperforms crizotinib as a treatment for patients with ALK-positive NSCLC who were naïve to ALK-targeted therapy

▲ Combinational immunotherapy of nivolumab and ipilimumab prolongs survival in comparison to standard chemotherapy in malignant pleural mesothelioma

▲ Pushing the bounds in early-stage lung cancer

▲ KRAS, HER2 & ALK: targeted options and sequencing issues

▲ Specific treatment approaches in the EGFR-mutated setting

▲ Interview: Antibody-drug conjugates: the age of almost unlimited possibilities has just begun

▲ What is new in SCLC?

▲ Immunotherapy: combination regimens and new data on the significance of mutations

▲ Interview: Lung cancer screening: hurdles in daily routine and in the research laboratory

▲ Nivolumab as a new option in patients with relapsed malignant mesothelioma

▲ J-AXEL: nab-paclitaxel at least equal to docetaxel in pretreated NSCLC

The memo inOncology Special Issue report is produced by Springer, as a supplement of memo (the Magazine of European Medical Oncology) and sponsored by Boehringer Ingelheim and BeiGene with an unrestricted educational grant. For more information on the memo inOncology Special Issue series, and for free access to all previous editions, visit the memo-inOncology website.

Download the full report (English)

Download the full report (Mandarin)